摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]-3-[[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-2(3H)-furanone

中文名称
——
中文别名
——
英文名称
(3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]-3-[[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-2(3H)-furanone
英文别名
(3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]oxolan-2-one
(3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]-3-[[4-(beta-D-glucopyranosyloxy)-3-methoxyphenyl]methyl]dihydro-2(3H)-furanone化学式
CAS
——
化学式
C27H34O11
mdl
——
分子量
534.6
InChiKey
XOJVHLIYNSOZOO-RVDKUWPISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    38
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    153
  • 氢给体数:
    4
  • 氢受体数:
    11

文献信息

  • Cosmetic compositions decreasing GM-CSF release induced by nickel salts
    申请人:Cognis IP Management GmbH
    公开号:EP1902755A1
    公开(公告)日:2008-03-26
    Suggested are cosmetic compositions comprising: (a) a working amount of at least one agent that decreases the GMCSF release induced by nickel salt and (b) a cosmetically acceptable excipient.
    建议的化妆品组合物包括 (a) 至少一种能减少镍盐诱导的 GMCSF 释放的制剂的工作量,以及 (b) 化妆品可接受的赋形剂。
  • Composition and method for treating skin by administering silybin and piperine/terahydropiperine
    申请人:Cognis IP Management GmbH
    公开号:EP1902756A1
    公开(公告)日:2008-03-26
    Suggested are cosmetic compositions comprising in a cosmetically acceptable excipient (a) silybin and (b) piperine and/or tetrahydropiperine. The compositions are suitable for preventing and/or soothing dry skin or reactive skin against external stresses.
    建议的化妆品组合物含有化妆品可接受赋形剂 (a) 水飞蓟宾和 (b) 胡椒碱和/或四氢哌啶。这些复合物适用于预防和/或舒缓皮肤干燥或皮肤对外界压力的反应。
  • Process for using phytochemicals and sugar acids to create one or more engineered media for use in a water purification filter
    申请人:Saha Anuj K
    公开号:US10059605B1
    公开(公告)日:2018-08-28
    The process for creating one or more engineered media for use in a water purification filter is a passive multi-stage multi-media filter for use in water purification. The process for creating one or more engineered media for use in a water purification filter removes harmful contaminants from a water stream including, but not limited to, toxic heavy metals and metalloids, pharmaceutical residues, micro-toxins, endocrine disrupters, chlorinated and other halogenated solvents, fluoride, nitrate, and naturally occurring radioactive contaminants. The process for creating one or more engineered media for use in a water purification filter maintains concentrations of phytochemicals that provide health benefits. Water processed through the process for creating one or more engineered media for use in a water purification filter meets United States, European Union and World Health Organization standards for safe drinking water.
    制造用于水净化过滤器的一种或多种工程介质的工艺是一种用于水净化的无源多级多介质过滤器。制造用于水净化过滤器的一种或多种工程介质的工艺可去除水流中的有害污染物,包括但不限于有毒重金属和类金属、药物残留物、微毒物、内分泌干扰物、氯化溶剂和其他卤化溶剂、氟化物、硝酸盐和天然放射性污染物。制造用于净水过滤器的一种或多种工程介质的工艺可以保持植物化学物质的浓度,从而为健康带来益处。通过制造用于净水过滤器的一种或多种工程介质的工艺处理的水符合美国、欧盟和世界卫生组织的安全饮用水标准。
  • Cosmetic Compositions
    申请人:Danoux Louis
    公开号:US20090298783A1
    公开(公告)日:2009-12-03
    Disclosed is a method for preventing and/or soothing dry or sensitive skin against external stresses, comprising contacting the skin with a composition including an agent that decreases the release of granulocyte-macrophage colony-stimulating factor (GMCSF) from keratinocytes in the skin, wherein under conditions of external stress, dry or sensitive skin is soothed and/or prevented. Agents that decrease the release of GMCSF include silybin, piperine, tetrahydropiperine, nortrachelogenine, rhapontin, arctiin, artigenin and mixtures thereof. Also disclosed is a method of identifying an agent that decreases the level of GMCSF released from keratinocytes.
查看更多

同类化合物

鹅掌楸碱 罗汉松树脂酚-4'-O-β-龙胆二糖苷 络石苷元-4'-O-BETA-龙胆二糖苷 络石苷 牛蒡苷 柑属苷B 松脂醇二葡萄糖苷 松脂醇-4-O-beta-D-吡喃葡萄糖苷 松脂醇 beta-D-吡喃葡萄糖苷 木須皮苷 异落叶松脂素-9'-O-beta-D-吡喃葡萄糖苷 开环异落叶松脂素BETA-D-葡糖苷 地菲林葡萄糖苷 南烛木糖甙 刺五加苷D 刺五加甙E 刺五加甙 E 刺五加提取物 丁香树脂醇双葡萄糖苷 b-D-吡喃葡萄糖苷,4-[(1R,2R)-1,3-二羟基-2-[4-[(1E)-3-羟基-1-丙烯-1-基]-2-甲氧基苯氧基]丙基]-2-甲氧苯基 Ssioriside; (2S,3S)-4-羟基-2,3-双[(4-羟基-3,5-二甲氧基苯基)甲基]丁基 beta-D-吡喃木糖苷 8-羟基松脂醇二葡萄糖苷 8-O-(α-阿拉伯呋喃糖)-β-àpeltatin 4-(1,3-苯并二氧戊环-5-基)-9-[(2S,3R,4S,5R)-3,4-二甲氧基-5-[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基四氢吡喃-2-基]氧基-6,7-二甲氧基-1H-苯并[f][2]苯并呋喃-3-酮 4-(1,3-苯并二氧戊环-5-基)-6,7-二甲氧基-9-[(2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-1H-苯并[f][2]苯并呋喃-3-酮 3-[2,3-二氢-6-羟基-2-(1-羟基-1-甲基乙基)苯并呋喃-5-基]-8-(beta-D-吡喃葡萄糖基)-2,3-二氢-5,7-二羟基-4H-1-苯并吡喃-4-酮 2,3-双(3-甲氧基-4-羟基苄基)丁烷-1,4-二醇 1,4-二葡萄糖甙 (3S,4R)-4-(苯并[1,3]二氧杂环戊烯-5-基甲基)-3-[(S)-[(2R,3R,4S,5R,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-(3,4,5-三甲氧基苯基)甲基]四氢呋喃-2-酮 (3R,4S)-3-[[4-(beta-D-吡喃葡萄糖基氧基)-3-甲氧基苯基]甲基]-4,5-二氢-4-[(4-羟基-3-甲氧基苯基)甲基]呋喃-2(3H)-酮 (-)-异落叶松脂素-9'-O-BETA-D-吡喃葡萄糖苷 (+)-南烛木树脂酚9'-O-葡萄糖甙 4-O-[2"-O-[6-[4-hydroxypiperidin-1-yl]hexyl]-3",4"-di-O-methyl-β-D-xylopyranosyl]diphyllin 4-O-[2"-O-[8-[4-hydroxypiperidin-1-yl]octyl]-3",4"-di-O-methyl-β-D-xylopyranosyl]diphyllin phyllanthusmin B (2S,3R,4S,5S)-2-((9-(benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxy-1,3-dihydronaphtho[2,3-c]furan-4-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (2S,3R,4S,5S)-2-((9-(benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxy-3-oxo-1,3-dihydronaphtho[2,3-c]furan-4-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate tri-O-acetylpatentiflorin A phyllanthusmin D 2")-β-D-xylopyranosyl-(1""->5")-β-D-apiofuranosyl]diphyllin">4-O-[α-L-arabinopyranosyl-(1"'->2")-β-D-xylopyranosyl-(1""->5")-β-D-apiofuranosyl]diphyllin (+)-syringaresinol 4-O-β-D-glucopyranosyl(1->6)-β-D-glucopyranoside liriodendrin 4-O-[6-O-(5-O-sinapoyl-β-D-apiofuranosyl)-β-D-glucopyranosyl]-(+)-(7S,7'S,8R,8'R)-4'-hydroxy-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane 4-O-[3″,4″-di-O-methyl-β-d-xylopyranosyl]diphyllin (+)-medioresinol di-O-β-D-glucopyranoside (-)-(8S,8'R)-4,4'-dihydroxy-3,3',5'-trimethoxylignan-4'-O-β-D-glucopyranoside (-)-nectandrin B-β-D-glucopyranoside (3S)-4''-O-β-D-Glucopyranosylhinokiresinol 4'-O-β-D-glucopyranosylhinokiresinol (7R,8R)-4,7,9,3′,9′-pentahydroxy-3-methoxy-8,4′-oxyneolignan-3′-O-β-D-glucopyranoside (7S,7'R,8R,8'S)-7'-butoxy-7,9'-epoxy-4,4',9-trihydroxy-3,3'-dimethoxylignane 9-O-β-D-glucopyranoside